Marksans Pharma

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue709.70723.80625.63741.98774.57
Expenses566.44607.71549.04608.65623.95
EBITDA166.62142.27105.76166.07180.89
EBIT145.93119.5382.67139.15156.56
Profit Before Tax143.26116.1076.60133.34150.62
Net Profit105.0790.7358.2099.14113.69
Financial Ratios
Operating Profit Margin24.43%20.08%17.06%23.05%23.98%
Net Profit Margin15.33%12.78%9.41%13.64%15.00%
Earning Per Share (Diluted)2.312.001.292.172.50
Dividends Per Share0.000.000.000.000.00